Considering the fact that oxytocin has cardiovascular protective properties and also manifests anti-inflammatory and antioxidant features, the hypothesis of the use of exogenous oxytocin in COVID-19 cases seems to be justified [28,30]. The gene discussed is OXT; the disease is COVID-19.